{
    "BJOG - 2024 - Nelson\u2010Piercy - The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum  Green\u2010top.pdf": "1. Nausea and Vomiting in Pregnancy (NVP)\n2. Hyperemesis Gravidarum (HG)\n3. Pregnancy-Unique Quantification of Emesis (PUQE)\n4. HyperEmesis Level Prediction (HELP)\n5. Ketonuria\n6. Antiemetics\n7. Anti (H1) histamines\n8. Phenothiazines\n9. Doxylamine/pyridoxine (Xonvea\u00ae)\n10. Ondansetron\n11. Metoclopramide\n12. Normal saline (0.9% NaCl)\n13. Potassium chloride\n14. Thiamine supplementation\n15. Termination of pregnancy\n16. Hyponatraemia\n17. Hypokalaemia\n18. Low serum urea\n19. Raised haematocrit\n20. Metabolic hypochloraemic alkalosis\n21. Liver function tests\n22. Transaminases\n23. Bilirubin\n24. Amylase\n25. Malnutrition Universal Screening Tool (MUST)\n26. Urinalysis\n27. Urea and electrolytes\n28. Full blood count\n29. Blood glucose level\n30. Ultrasound scan\n31. Thyroid function tests\n32. Calcium and phosphate\n33. Venous blood gas\n34. Parenteral administration\n35. Transdermal administration\n36. Rectal administration\n37. Corticosteroids\n38. Dystonic reactions\n39. Proton pump inhibitors\n40. Thromboprophylaxis\n41. Low-molecular-weight heparin\n42. Graduated compression stockings\n43. Venous thromboembolism\n44. Iron-containing preparations\n45. Laxatives\n46. Gastro-oesophageal reflux\n47. Diabetes mellitus\n48. Gastric band\n49. Gastric bypass\n50. Gastric sleeve surgery\n51. Oesophago-gastroduodenoscopy\n52. Haematemesis\n53. Severe epigastric pain\n54. Wernicke encephalopathy\n55. Vitamin B1 deficiency\n56. Fetal growth\n57. Dextrose infusions\n58. Wernicke encephalopathy\n59. Quality of life\n60. Depression\n61. Anxiety\n62. Postnatal depression\n63. Post-Traumatic",
    "Reduced Fetal Movements UHS-CG-0015-2023.pdf": "1. Reduced Fetal Movements Guideline\n2. Pregnant women\n3. People experiencing reduced fetal movements\n4. Labour Ward obstetric Leads\n5. Clinical Effectiveness Midwife\n6. Obstetric medical and midwifery staff\n7. RCOG 2011 Green-top guideline No.57\n8. AFFIRM trial 2016\n9. NHS England: Saving babies\u2019 lives v3.1\n10. Avoidable still births\n11. Reporting reduced fetal movements\n12. Midwives and Obstetricians\n13. Trust and National Recommendations\n14. Fetal \u2018sleep\u2019 cycles\n15. Reduced Fetal Movements (RFMs)\n16. Small-for-gestational age (SGA) fetus\n17. Placental insufficiency\n18. Congenital malformations\n19. High risk maternal and birthing person conditions\n20. Hypertension\n21. Diabetes\n22. Auto-immune diseases\n23. Chronic kidney disease\n24. Anteriorly positioned placenta\n25. Sedating drugs\n26. Fetal malformations\n27. Fetal position\n28. Maternity unit\n29. Impending fetal death\n30. Risk factors for small-for-gestational-age\n31. Fetal viability\n32. Blood pressure\n33. Protein in urine\n34. Computerised CTG\n35. Antenatal assessment\n36. Day Assessment Unit\n37. Ultrasound scan\n38. Anomaly scan\n39. Fetal medicine consultant\n40. Serial growth scans\n41. Liquor volume\n42. Umbilical artery dopplers\n43. Induction of labour\n44. Cesarean birth\n45. Fetal growth restriction (FGR)\n46. Tommy\u2019s leaflet\n47. Continuous monitoring in labour\n48. Expedited birth\n49. Induction of labour\n50. Care plan\n51. Process indicators\n52. Outcome indicators\n53. Stillbirths\n54. Senior obstetrician review.",
    "Carbetocin to prevent PPH at CS UHS-CG-0009-2023.pdf": "1. Carbetocin\n2. Postpartum haemorrhage (PPH)\n3. Caesarean birth\n4. Synthetic analogue of oxytocin\n5. Specialist obstetric units\n6. Contraindicated\n7. Theatre/ODP team\n8. Anaesthetist\n9. Obstetrician\n10. Midwife\n11. Administer Carbetocin\n12. Umbilical cord clamping\n13. Dose: 100\u202fmicrograms\n14. Diluted with 0.9% sodium chloride\n15. Contraindications: pregnancy, labour before birth, hypersensitivity to Carbetocin or oxytocin, hepatic or renal disease, serious cardiovascular disorders, epilepsy, severe eclampsia or pre-eclampsia\n16. Cautions: cardiovascular disease, severe hypotension, hyponatraemia or water intoxication, pre-eclampsia or eclampsia, general anaesthesia, migraine, asthma\n17. Elimination half-life of Carbetocin: >40 minutes\n18. Clinical effect: up to 4 hours\n19. 2nd line agent\n20. Uterine tone\n21. Uterotonic activity\n22. Retained placental fragments\n23. Blood coagulation disorders\n24. Single administration\n25. Intramuscular or intravenous\n26. Uterotonics\n27. Uterine hypotonia or atonia\n28. Excessive bleeding\n29. Antidiuretic activity\n30. Hyponatraemia\n31. Interactions with other drugs\n32. Adverse effects: anaemia, headache, tremor, nausea, hypotension, flushing, chest pain, dyspnoea, pruritis, back pain, general discomfort\n33. Monitoring and review of compliance with guidelines\n34. Review of incident cases.",
    "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy.pdf": "- Obesity in pregnancy\n- Primary care services\n- Childbearing age\n- Weight optimization before pregnancy\n- BMI 30 kg/m2 or greater\n- Risks of obesity during pregnancy and childbirth\n- Weight loss before conception\n- Folic acid supplementation\n- Antenatal clinics\n- Maternity units\n- Environmental risk assessment\n- Weight and height measurement\n- BMI calculation\n- Third trimester\n- Dietetic advice\n- Anti-obesity or weight loss drugs\n- Obstetric anaesthetist\n- Risk assessment\n- Gestational diabetes\n- NICE or Scottish Intercollegiate Guidelines\n- Hypertensive complications\n- Pre-eclampsia\n- Aspirin\n- NICE CG107\n- Venous thromboembolism (VTE)\n- RCOG GTG No. 37b\n- Mental health problems\n- Chromosomal anomalies\n- Antenatal screening\n- Transvaginal ultrasound\n- Nuchal translucency measurements\n- Structural anomalies\n- Symphysis fundal height (SFH)\n- Ultrasound\n- Labour and birth\n- Obstetrician and anaesthetist\n- Postpartum haemorrhage (PPH)\n- Planned caesarean section\n- Multidisciplinary approach\n- VBAC\n- Intrapartum care\n- Cannula\n- NICE CG132\n- Postoperative wound care\n- Wound infection\n- Prophylactic antibiotics\n- Subcutaneous fat\n- Suturing\n- Breastfeeding\n- Postnatal contraception\n- Nutritional advice\n- Weight management services\n- Bariatric surgery\n- Nutritional deficiencies\n- Consultant-led antenatal care\n- Dietician\n- RCOG Green-top Guidelines (GTGs)\n- Cochrane Library, EMBASE, MEDLINE, and Trip\n- Preconception counselling\n- Orlistat\n- Phentermine/topiramate\n- Lorcaserin hydrochloride\n- Anaesthetic-related complications\n- Maternal mortality\n- Pressure sores\n- Cuff size for blood pressure measurements\n- Depression and anxiety\n- Congenital cardiac defects\n- Noninvasive prenatal testing (NIPT)\n- Fetal anomaly scans\n- Repeat scans\n- NICE CG62\n- RCOG GTG No. 31\n- NICE CG190\n- Stillbirth\n- P",
    "CG22001 UH Sussex Perinatal Mental Health guideline.pdf": "1. UH Sussex Perinatal Mental Health Guideline\n2. Maternity staff\n3. Perinatal mental health risks\n4. Care pathways\n5. Midwifery staff\n6. Obstetric consultants\n7. Obstetric anaesthetists\n8. CNST Maternity Standards\n9. Care Quality Commission\n10. NICE 2020 Antenatal and Postnatal Mental Health\n11. CEMACE Saving Mothers Lives 2006 \u2013 2008\n12. Anxiety disorders\n13. Postpartum psychosis\n14. Psychotropic medication\n15. Severe mental illness\n16. Traumatic birth\n17. Maternal death\n18. Mental health problems\n19. Risk factors\n20. Maternal mental health antenatal care pathway\n21. Antenatal care pathway\n22. Urgent review pathway\n23. NHS Talking Therapy\n24. Specialist Perinatal Mental Health Service (SPMHS)\n25. Mood stabilising or antipsychotic medication\n26. Fear of childbirth\n27. Bipolar disorder\n28. Severe postnatal depression\n29. Healthy Futures Team\n30. Specialist Public Health Nursing Service\n31. Perinatal Bereavement Service\n32. Maternal emotional wellbeing\n33. Skin-to-skin contact\n34. Trauma-informed care\n35. 32 week pre-birth planning meeting\n36. Perinatal mental health care plan\n37. Psychiatric emergency\n38. Hospital Mental Health Liaison Team\n39. Mental Health Act (1983)\n40. Mother and Baby Unit (MBU)\n41. Urgent Review Pathway\n42. Tocophobia\n43. Language barriers\n44. Mental capacity\n45. Medication in pregnancy and breastfeeding\n46. Specialist Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs\n47. Specialist Pharmacy Service\n48. Carbamazepine\n49. Lamotrigine\n50. Lithium\n51. Paroxetine\n52. Sodium Valproate\n53. Olanzapine and Quetiapine\n54. Venlafaxine\n55. SSRIs\n56. Fluoxetine, Citalopram, Sertraline\n57. BUMPS, TOXBASE, LACTMED, and UK DRUGS IN LACTATION ADVISORY SERVICE (UKDILAS)\n58. Whooley",
    "UHS Intrahepatic Cholestasis(ICP) UHS-CG-0001-2023.pdf": "1. UH Sussex Intrahepatic Cholestasis of Pregnancy (ICP) Guideline\n2. Leads for Maternity Risk Management\n3. Labour Ward Leads\n4. Joint Obstetric Guidelines Group\n5. Obstetric medical staff\n6. Midwives\n7. Diagnosis and management of ICP\n8. RCOG 2022 Green top guideline No 43\n9. UH Sussex: Labour and Antenatal Risk Assessments\n10. UH Sussex: Patient Information: Obstetric Cholestasis\n11. Maternal and perinatal risks\n12. Antenatal care\n13. Drug treatment\n14. Timing of birth/induction of labour\n15. Intrapartum care\n16. Postnatal care\n17. Subsequent pregnancies\n18. Audit\n19. Prevalence of ICP\n20. Genetics, racial background, and environmental factors\n21. Itching in skin of normal appearance\n22. Raised peak random total bile acid concentration\n23. Liver function tests\n24. Bile acid measurement\n25. Polymorphic Eruption of Pregnancy (PEP)\n26. Pemphigoid Gestationis\n27. Pre-eclampsia\n28. Gestational diabetes\n29. Stillbirth risk\n30. Consultant led care\n31. Weekly BA & LFTs measurements\n32. Topical emollient\n33. Antihistamine agents\n34. Ursodeoxycholic acid\n35. Co-morbidities\n36. Peak BA concentration\n37. Late preterm gestation\n38. Baby monitoring\n39. Continuous electronic fetal monitoring (CEFM)\n40. Adverse perinatal outcomes\n41. Baseline liver function test\n42. Bile acid concentration\n43. RCOG suggested audit questions."
}